Syndecan-1 (CD138) and Ki-67 expression in different subtypes of ameloblastomas
Ronell Bologna‐Molina(Universidad de la República de Uruguay), Pablo Damián‐Matsumura(Universidad Autónoma Metropolitana), José Eduardo Farfán-Morales(Instituto Nacional de Pediatria), Oslei Paes de Almeida(Universidade Estadual de Campinas (UNICAMP)), María Esther Irigoyen‐Camacho(Universidad Autónoma Metropolitana), Daniel Carrasco‐Daza(Instituto Nacional de Pediatria), Adalberto Mosqueda‐Taylor(Universidad Autónoma Metropolitana), F.J. García-Vázquez(Instituto Nacional de Pediatria), Eduardo López‐Corella(Instituto Nacional de Pediatria)
Cited by 83
Related Papers
Comparison of the value of PCNA and Ki-67 as markers of cell proliferation in ameloblastic tumors
|Medicina oral, patología oral y cirugía bucal|2012|253
Extranodal NK/T cell lymphoma, nasal type: An updated overview
|Critical Reviews in Oncology/Hematology|2021|111
Oral medicine (stomatology) across the globe: birth, growth, and future
|Oral Surgery Oral Medicine Oral Pathology and Oral Radiology|2015|66
Comparative expression of syndecan‐1 and Ki‐67 in peripheral and desmoplastic ameloblastomas and ameloblastic carcinoma
|Pathology International|2009|62
Current concepts in ameloblastoma-targeted therapies in B-raf proto-oncogene serine/threonine kinase V600E mutation: Systematic review
|World Journal of Clinical Oncology|2019|58